Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading

Next Previous
X
Search
Trial Profile

Study of the effect of Anagliptin administration on the activity of glucagon after test meal loading

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics

    • Most Recent Events

    • 18 Jun 2018 Status changed from recruiting to completed.
    • 13 Jul 2017 According to UMIN, the date for data entry closure is 2018/02/28 , and the date for conclusion of data analysis is 2018/04/30.
    • 13 Jul 2017 Planned End Date changed from 31 Jul 2017 to 31 Jan 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top